| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/09/2023 | 454.02% | Stifel | $20 → $10 | Maintains | Buy |
| 07/27/2023 | 897.23% | Piper Sandler | $14 → $18 | Upgrades | Underweight → Neutral |
| 07/07/2023 | 1229.64% | Stifel | $35 → $24 | Maintains | Buy |
| 06/12/2023 | 2226.87% | Stephens & Co. | → $42 | Reiterates | Overweight → Overweight |
| 05/16/2023 | 2226.87% | Stephens & Co. | → $42 | Reiterates | Overweight → Overweight |
| 05/11/2023 | — | William Blair | Downgrades | Market Perform → Underperform | |
| 05/10/2023 | 1063.43% | Cantor Fitzgerald | $33 → $21 | Maintains | Neutral |
| 05/10/2023 | 675.62% | Piper Sandler | → $14 | Reinstates | → Underweight |
| 04/14/2023 | 2448.48% | Stephens & Co. | → $46 | Reiterates | → Overweight |
| 04/10/2023 | 2448.48% | Stephens & Co. | → $46 | Reiterates | → Overweight |
| 03/30/2023 | — | Maxim Group | Downgrades | Buy → Hold | |
| 01/31/2023 | — | William Blair | Initiates Coverage On | → Market Perform | |
| 01/12/2023 | 2947.09% | Maxim Group | $80 → $55 | Maintains | Buy |
| 01/11/2023 | 1728.25% | Cantor Fitzgerald | $85 → $33 | Downgrades | Overweight → Neutral |
| 12/28/2022 | 3667.31% | Stephens & Co. | $78 → $68 | Maintains | Overweight |
| 10/14/2022 | 4221.33% | Stephens & Co. | → $78 | Reinstates | → Overweight |
| 08/05/2022 | 2947.09% | Piper Sandler | $65 → $55 | Maintains | Overweight |
| 11/04/2021 | 3224.1% | Maxim Group | → $60 | Upgrades | Hold → Buy |
| 06/02/2021 | 2947.09% | Cantor Fitzgerald | → $55 | Initiates Coverage On | → Overweight |
| 11/05/2020 | 1451.25% | Piper Sandler | $22 → $28 | Maintains | Overweight |
| 09/30/2020 | 1118.84% | Piper Sandler | $18 → $22 | Maintains | Overweight |
| 05/05/2020 | 1340.44% | Stifel | $32 → $26 | Upgrades | Hold → Buy |
| 04/22/2020 | 897.23% | Piper Sandler | → $18 | Initiates Coverage On | → Overweight |
| 03/23/2020 | 731.02% | Stephens & Co. | $45 → $15 | Maintains | Overweight |
| 02/25/2020 | 1672.85% | Stifel | $36 → $32 | Maintains | Hold |
What is the target price for Cutera (CUTR)?
The latest price target for Cutera (NASDAQ: CUTR) was reported by Stifel on November 9, 2023. The analyst firm set a price target for $10.00 expecting CUTR to rise to within 12 months (a possible 454.02% upside). 15 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cutera (CUTR)?
The latest analyst rating for Cutera (NASDAQ: CUTR) was provided by Stifel, and Cutera maintained their buy rating.
When is the next analyst rating going to be posted or updated for Cutera (CUTR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cutera, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cutera was filed on November 9, 2023 so you should expect the next rating to be made available sometime around November 9, 2024.
Is the Analyst Rating Cutera (CUTR) correct?
While ratings are subjective and will change, the latest Cutera (CUTR) rating was a maintained with a price target of $20.00 to $10.00. The current price Cutera (CUTR) is trading at is $1.81, which is out of the analyst's predicted range.
